CoreCap Advisors
WVE icon

CoreCap Advisors’s Wave Life Sciences WVE Stock Holding History

CoreCap Advisors’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-28
Closed -$163 – 3371
2026
Q2 		$163 Buy
+28
New +$186 ﹤0.01% 3029
2025
Q2 		– Sell
-24
Closed -$194 – 3279
2025
Q1 		$194 Buy
+24
New +$262 ﹤0.01% 2988

Other funds holding WVE

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
James J. Burns & Company
James J. Burns & Company Melville, New York $937M AUM 13.35% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

CoreCap Advisors's WVE Position: Q3 2026 in Review

CoreCap Advisors sold out of Wave Life Sciences (WVE) in Q3 2026, closing a stake of 28 shares — an estimated $163 sold.

CoreCap Advisors first reported a position in WVE in Q1 2025 and held it in 2 quarters. The position peaked at $194 in Q1 2025. 16 funds tracked by Wall St. Rank hold WVE as of Q3 2026.

  • CoreCap Advisors reported no remaining Wave Life Sciences position as of Q3 2026 after selling out during the quarter.
  • CoreCap Advisors sold 28 Wave Life Sciences shares in Q3 2026, an estimated $163.
  • CoreCap Advisors first reported a position in Wave Life Sciences in Q1 2025 and held it in 2 quarters.
  • CoreCap Advisors's Wave Life Sciences position peaked at $194 in Q1 2025.
  • 16 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.